Michael William Pennington
Hoofd Techniek/Wetenschap/O&O bij Ambio Pharmaceuticals
Actieve functies van Michael William Pennington
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Hoofd Techniek/Wetenschap/O&O | 16-06-2021 | - |
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Hoofd Techniek/Wetenschap/O&O | 04-03-2019 | - |
| Verkoop & Marketing | 16-02-2018 | 04-03-2019 |
Loopbaan van Michael William Pennington
Eerdere bekende functies van Michael William Pennington
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Peptides International LLC
 Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Algemeen Directeur | 01-10-2012 | 01-02-2018 |
| Hoofd Techniek/Wetenschap/O&O | 01-12-2010 | 01-10-2012 | |
| Bachem Bioscience, Inc. | Operationeel Directeur | 01-07-2000 | 01-08-2010 |
| Hoofd Techniek/Wetenschap/O&O | 01-12-1992 | 01-07-2000 |
Opleiding van Michael William Pennington
| University of Florida | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Kaaimaneilanden | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 1 |
| Sales & Marketing | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
| Bachem Bioscience, Inc. | |
Peptides International LLC
Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Health Technology |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Health Technology |
